Respiratory drug developer Vectura has announced the appointment of former Almirall Executive Director of R&D Per-Olof Andersson as a Non-Executive Director of the Board. Before Almirall, he worked for almost two decades for Pharmacia and Pfizer. Andersson retired from Almirall in 2011 and has been working as an independent consultant since that time. Vectura … [Read more...] about Vectura appoints Per-Olof Andersson as Non-Executive Director
People
Insmed appoints Eugene Sullivan Chief Medical and Scientific Officer
Arikayce inhaled liposomal amikacin developer Insmed Incorporated has announced the appointment of Eugene Sullivan, a former FDA Deputy Director of the Division of Pulmonary and Allergy Products, as Chief Medical and Scientific Officer. Sullivan has also served as Chief Medical Officer of United Therapeutics and VP, Global Regulatory Affairs at Astra Zeneca. … [Read more...] about Insmed appoints Eugene Sullivan Chief Medical and Scientific Officer
KCL’s Abhinav Kumar to work with Inhalation Sciences on dissolution project
2014 Pat Burnell New Investigator Award winner Abhinav Kumar of King’s College London will collaborate with Inhalation Sciences AB onsite in Stockholm, Sweden, the company has announced. The joint research project will explore the use of KCL's simulated lung fluid for in vitro dissolution testing. The KCL team has already been using ISAB's DissolvIt module with the … [Read more...] about KCL’s Abhinav Kumar to work with Inhalation Sciences on dissolution project
Recipharm names Thomas Beck as VP Quality Management
Swedish CDMO Recipharm has announced the appointment of Thomas Beck to the new senior role of Vice President Quality Management, effective April 1, 2015. Beck has been Head of Quality Control and Assurance at Recipharm Stockholm since 2010 and also serves as chairman of the Quality Assurance section of the Swedish Academy of Pharmaceutical Science. Recipharm offers … [Read more...] about Recipharm names Thomas Beck as VP Quality Management
Insmed confirms filing of MAA for Arikayce, announces new hires
In its announcement of fourth quarter and full year financial results for 2014, Insmed has confirmed that it filed an MAA for Arikayce liposomal amikacin inhalation solution. The company said that the EMA's Pediatric Committee has approved the Pediatric Investigation Plan for the product, and the MAA has subsequently been validated. Insmed also announced the … [Read more...] about Insmed confirms filing of MAA for Arikayce, announces new hires
Tyler Martin joins Dance Biopharm as President
Dance Biopharm has announced the appointment of former Dynavax chief medical officer and president J. Tyler Martin as President, a newly created position. Martin has also been appointed a member of the board of directors. From 2003-2006, Martin was a vice president of Chiron, where he worked on the development of Tobi tobramycin inhalation powder. Dance Chairman … [Read more...] about Tyler Martin joins Dance Biopharm as President
Respira hires Andy Clark as VP and Chief Technology Officer
DPI developer Respira Therapeutics has hired inhalation drug development pioneer Andy Clark as Vice President and Chief Technology Officer. Clark most recently served as Site Head and CTO at the Novartis pulmonary development facility in San Carlos, CA. He previously served as CTO at Nektar/Inhale and held positions at Genentech and Fisons. Clark, a past president … [Read more...] about Respira hires Andy Clark as VP and Chief Technology Officer
Arvind Agrawal joins Lightlake Therapeutics
Lightlake Therapeutics has announced today that it has hired former Mundipharma Head of Medical Affairs for New Products Arvind Agrawal as Executive VP, Medical Affairs, effective January 2015. Agrawal has also held Medical Affairs positions at Reckitt Benckiser and AstraZeneca. In December 2014, Lightlake announced that it had licensed its intranasal naloxone … [Read more...] about Arvind Agrawal joins Lightlake Therapeutics
Chris Blackwell to step down as Vectura Chief Executive
Vectura Chief Executive Chris Blackwell will step down from that position at the end of June 2015, the company has announced. Blackwell has been with the company since 2002. The company's board says that it plans a search for a new chief executive. Vectura licenses its DPI devices and formulations to numerous pharmaceutical companies, most recently announcing a … [Read more...] about Chris Blackwell to step down as Vectura Chief Executive
Alfred Mann steps down as CEO of MannKind Corporation, company gets milestone payment for Afrezza
According to MannKind Corporation, Hakan Edstrom has taken over as CEO after company founder Alfred Mann stepped down from that position effective January 9, 2015. Mann will become the Executive Chairman and "intends to remain engaged with the company in business matters, including those relating to development and financing of MannKind's future therapies," the … [Read more...] about Alfred Mann steps down as CEO of MannKind Corporation, company gets milestone payment for Afrezza